Community

Attendees of the breast cancer awareness symposium “Bridging the Gap: Promoting Breast Cancer Prevention, Screening and Wellness” were given the chance to submit questions on breast cancer in the minority community. This is the second part of these questions answered by Dr. Preya Ananthakrishnan, Assistant Professor of Clinical Surgery and a host of the event.

Q: Does removing a breast that is not cancerous mean the cancer can or will occur somewhere else?

Dr. Ananthakrishnan: Removing a breast that is not cancerous (called prophylactic mastectomy) decreases the chances that a cancer will form in the opposite breast, however does not have any impact on whether the cancer will occur somewhere else.

Q: Does Arimedex affect joints and vision?

Dr. Ananthakrishnan: Yes, anastrazole (Arimidex) can cause joint pain. Vision changes should be reported immediately to your doctor, particularly if associated with headaches, confusion, or difficulty with speech or balance. This could be a medical emergency that would require immediate attention.

Q: Is it recommended that I take Tamoxifen as a prevention for breast cancer? What are the side effects? Is it possible to get a list of the suggested preventative foods mentioned by Dr. Crew?

Dr. Ananthakrishnan: The benefits of your taking Tamoxifen for breast cancer prevention depend on your individualized risk of breast cancer, which should be discussed with your doctor or a medical oncologist. Side effects of Tamoxifen include blood clots, strokes, uterine cancer, and cataracts. Other less serious side effects include hot flashes, vaginal dryness, leg cramps, and joint pain.

Q: I had an abdominal, pelvic & chest CT scan in January, April & now scheduled for a chest CT in June. Last because of chest pain & abdominal discomfort. Is this too much radiation with contrast & non-contrast scans?

Dr. Ananthakrishnan: While you would like to limit your radiation exposure from imaging studies as much as possible, if you are having serious symptoms then the benefits of detecting a problem on the scans are likely to outweigh the risks of the additional radiation. However, perhaps you could speak with your doctor to see whether the tests could be spaced out more if the symptoms you are experiencing have not changed in the interim.

Q: What is the increased risk for breast cancer development for women who have had abortions?

Dr. Ananthakrishnan: History of abortions does not increase risk for breast cancer. (You can refer to the: Summary Report: Early Reproductive Events and Breast Cancer Workshop for even more information on this.)

Q: My breast are large and mammograms are painful. Are there any alternatives – holistic or otherwise? The pressing seems un-natural and looks like it would cause other problems.

Dr. Ananthakrishnan: While mammograms are painful, unfortunately at this time there are no well accepted alternatives to mammography. The FDA came out with a statement in early June that thermography is not a substitute for screening mammography.

Q: When you mentioned a relative getting cancer at an early age may mean you are at a higher risk, is it any relative?

A first degree relative (mother, sister, or daughter) with a breast cancer increases risk more so than a distant relative.

Watch for Part 3 of this article, “Bridging the Gap: Your Questions & Answers on Breast Cancer from Dr. Preya Ananthakrishnan and Dr. Katherine Crew” to be posted shortly on columbiasurgery.net.

{ 3 comments }

Preya Ananthakrishnan, MD

Preya Ananthakrishnan, MD

Attendees of the breast cancer awareness symposium “Bridging the Gap: Promoting Breast Cancer Prevention, Screening and Wellness” were given the chance to submit questions on breast cancer in the minority community. This is the first part of these questions answered by Dr. Preya Ananthakrishnan, Assistant Professor of Clinical Surgery and a host of the event.

Q: I am a 51 year old Black women, whose mother died 13 years ago from breast cancer & her sister was diagnosed last year. I had a mammography 2 weeks ago and got the dreaded come back letter. Should I get genetic counseling?

Dr. Ananthakrishnan: I would suggest that your sister with the breast cancer get tested first, and if her test result is positive then you should get tested. Furthermore, it is likely that even though you got a “call back” letter after your mammogram, it is very possible that you don’t actually have a breast cancer. I would advise you to go in as soon as possible to work up whatever abnormality was seen. If you do in fact have a breast cancer, then you should certainly undergo genetic testing yourself.

Q: What is considered “early detection” of breast cancer?

Dr. Ananthakrishnan: Early detection is finding a breast cancer before symptoms actually occur. This could be by finding it on a mammogram before actually feeling a lump in the breast, or by finding a small lump before it becomes a big lump. Early detection can sometimes allow for less aggressive treatments and improved outcomes.

Q: Is radical mastectomy surgery still performed? I hear little about it now.

Dr. Ananthakrishnan: Radical mastectomy which involves removing the pectoralis major muscle along with the breast above it is now rarely performed.

Q: After 40 years old, I thought instead of every year, mammography would be every 2 years. Is this correct?

Dr. Ananthakrishnan: This is based on the USPTF task force recommendations which came out in 2010, however these recommendations have not been widely adopted. Current recommendations by the American Cancer Society still include annual mammography in women over age 40.

Q: I watch the Dr. Oz Show and he spoke about a shield to cover your neck when having a mammogram. What are your thoughts on the subject?

Dr. Ananthakrishnan: The American College of Radiology does not recommend using a thyroid shield, since the amount of radiation the thyroid is exposed to is so low during a mammogram. In addition, use of a shield can cause artifact in the mammogram (meaning shadows or other findings that can make your mammogram more difficult to read,) which would mean that your mammogram would have to be repeated. This would expose you to even more radiation than if you had not used the thyroid shield in the first place.

Q: Breast Cancer and HIV – can you treat both and which is the priority to treat first?

Dr. Ananthakrishnan: Yes, breast cancer can absolutely be treated in patients with HIV. In fact, the patients do very well from both diseases. The idea is to keep the HIV under control with maintenance therapy, and treat the breast cancer as aggressively as it would be treated in a non-HIV patient.

Q: Is Arimidex, a chemoprevention drug used as readily as Evista or Tamoxifen – why or why not?

Dr. Ananthakrishnan: The aromatase inhibitor drugs include anastrazole (Arimidex), exemestane (Aromasin), and letrozole (Femara). Anastrazole is currently being studied for its role in chemoprevention, as part of the IBIS-II trial. Recent data was just reported earlier in June at the ASCO conference that exemestane reduces the risk of an initial breast cancer occurrence. Concerns about using the aromatase inhibitors for breast cancer prevention are mainly related to side effect profiles, including bone pain and joint pain.

Q: Can I drink green tea if taking Lovenox? (80 mg every 12 hours)

Dr. Ananthakrishnan: Talk to your physician about this. The concern about green tea and anticoagulants is that green tea contains vitamin K, which can make some anticoagulants ineffective.

Q: Shortly after being diagnosed with breast cancer I started feeling a pain in my thigh. I had a PET-scan, X-ray, Venous & Doppler all coming back negative. Any suggestions on a cause or treatment?

Dr. Ananthakrishnan: It is best to discuss this with your physician, since a physical exam would also be helpful in determining the etiology of your pain.

Related Link:
Bridging the Gap: Your Questions & Answers on Breast Cancer from Dr. Preya Ananthakrishnan Part 2

{ 4 comments }

June 2011 Breast Cancer Symposium at Club 101

by Columbia Surgery on June 20, 2011

from l to r: Dr. Monet Bowling, Dr. Sheldon Feldman, and Dr. Preya Ananthakrishnan

On Saturday, June 4, NewYork-Presbyterian Hospital/Columbia University Medical Center hosted a free community breast cancer awareness symposium called “Bridging the Gap: Promoting Breast Cancer Prevention, Screening and Wellness.” More than 200 women, many of whom were breast cancer survivors, attended the event.

Held at Club 101 in Manhattan, NY, the symposium involved more than just a delicious breakfast and lunch; the event featured leading figures in breast cancer research speaking on a variety of subjects, ranging from breast cancer prevention and treatment to more general topics such as sexual health, nutrition, and stress relief. In addition to the speeches, meals, and informative breakout sessions, there were group exercises in meditation, yoga, and Reiki. Several community-based organizations were also present, sharing information about the services they offer locally.

The event was hosted by Preya Ananthakrishnan, MD, Sheldon Feldman, MD, and Katherine Crew, MD, and organized by Columbia University Medical Center’s Department of Surgery, The Herbert Irving Comprehensive Cancer Center’s Research Recruitment Minority Outreach, and the Columbia University Cancer Screening Partnership.

Bridging the Gap Eileen Z Fuentes

Eileen Z. Fuentes,
Wellness Guru & Breast Cancer Survivor

Related Link:
Bridging the Gap: Your Questions & Answers on Breast Cancer from Dr. Preya Ananthakrishnan Part 1

{ 2 comments }

WebmedCentral, an online portal for biomedical publications, has selected M. Wasif Saif, MD, MBBS, to serve on its Advisory Board. Members of this board are selected from among the most accomplished international scientists. As one of its newest members, Dr. Saif will help guide Webmed Central in issues relating to policy, services, publishing, and science.

WebMed Central

Dr. Saif feels privileged to be associated with Webmed Central, which provides an innovative platform for rapid and free dissemination of biomedical knowledge. “Barriers to publishing need to be reduced, and every scientist should have an opportunity to contribute,” says Dr. Saif. “The traditional system of review needs to be broadened in its scope to accommodate every comment or criticism of the published work. Publishing and peer review is a time-consuming and cost intensive exercise, but Webmed Central’s post-publishing peer review process makes it more efficient, accountable, economical, unbiased, and transparent.”

M. Wasif Saif, MD, MBBS, is Medical Director, Pancreas Center, NewYork-Presbyterian/Columbia; Director, GI Oncology Section, Division of Hematology/Oncology; and Professor of Clinical Medicine, Division of Hematology/Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons

{ 0 comments }

Sharecare Logo

Have you ever had a pressing health question and you couldn’t find clear answers on your own, or you didn’t have an expert available to ask? Now you do.

Faculty from Columbia University Medical Center’s Department of Surgery have partnered with Sharecare.com, a free website that directly connects the public with medical experts to provide clear, responsible health information. The highly interactive platform allows visitors to ask health-related questions, which are then answered online by top medical professionals. Expert partners include hospitals, physicians, surgeons, healthcare companies, non-profit organizations, and others.

“The Department of Surgery is very pleased to be partnering with Sharecare to provide accurate, reliable health information to the public. It is important for patients to have a reliable source to ask questions, receive timely answers, and feel empowered in their healthcare decisions,” says Deborah Schwarz, Executive Director and Chief Communications Officer of the Columbia University Department of Surgery.

{ 0 comments }

Bridging the Gap

Bridging the Gap:
Promoting Breast Cancer Prevention, Screening and Wellness

Saturday, June 4, 2011
8:30am – 2:30pm
Club 101, NYC

Breast cancer is the most common cancer among American women, except for skin cancers. It is the second leading cause of cancer death in women, exceeded only by lung cancer. White women are more likely to get breast cancer in their lifetime than women in other racial groups, but African American and Latina women are more likely to die from the disease.

Low-income women and women of color are dying in disproportionate numbers because of the barriers that they face while fighting the disease:

  • White women over the age of 40 are significantly more likely to have had a mammogram in the last two years than women in other groups.
  • Women of color are diagnosed at a later stage than white women, resulting in a higher risk of death and more disabling treatment.
  • Access to high-quality health care, lack of insurance, and the concentration of polluting industries in communities of color and low-income neighborhoods all contribute to women of color suffering a disproportionate impact from breast cancer.

It is the goal of the Clinical Breast Cancer Program, NewYork-Presbyterian/Columbia Department of Surgery, to bridge this gap through education and prevention.

Bridging the Gap is free and open to the public, but registration is required. Bring your friends and family for a day of demonstrations, lectures, exhibits, giveaways, survivor testimonials and more!

For more information/reservations: Christine Rein
Telephone: 201.346.7014 Fax: 201.346-7011
E-mail: cmr2146@columbia.edu
Online: registration page

{ 1 comment }

PurpleStride Manhattan 2011 Walk

PurpleStride Manhattan 2011


Pancreatic Cancer Action Network
PurpleStride Manhattan 2011
5k Run/Walk
Sunday, May 22, 2011
Riverside Park at 10 A.M.

Please help support the fight against pancreatic cancer by participating in the PurpleStride Manhattan 2011 walk. Patients, family members, friends, physicians, and staff at The Pancreas Center will be participating in this annual event. All proceeds benefit the Pancreatic Cancer Action Network.

Enjoy a 5k run/walk in Manhattan’s most spectacular waterfront park, with views of the Hudson River. There will be entertainment, children’s activities, refreshments, dedications and presentations to honor and memorialize loved ones. The event is perfect for the whole family.

Read a special message from Honorary Chair Katie Couric.

Register online by May 1 to guarantee a T-shirt in your size.
REGISTER TODAY!

For more information about The Pancreas Center at NewYork-Presbyterian Hospital/Columbia University Medical Center, please visit our site.

{ 0 comments }

Team Gratitude at the 2010 NYC Liver Life Walk

Team Gratitude at the 2010 NYC Liver Life Walk

Are you, a family member, or a friend affected by liver disease? Help make a difference by walking with NewYork-Presbyterian’s Team Gratitude this spring.

The annual American Liver Foundation NYC Liver Life Walk will be held Sunday, June 5, 2011 in Battery Park, NY.

Team Gratitude includes patients with liver disease, liver transplant donors and recipients, friends, family members, physicians, and others connected through NewYork-Presbyterian Hospital Center for Liver Disease & Transplantation. Celebrating its tenth year, the team is united in its commitment to fight liver disease. As part of that commitment, members walk for many reasons: to raise awareness about liver disease, to improve prevention of liver disease by raising funds for the American Liver Foundation; to walk in memory of a loved one; to represent the 30 million Americans fighting liver disease today; and to walk in gratitude towards life.

To join Team Gratitude at the NYC Walk, go to the Team Gratitude team web page. Scroll down the page to see the list of team members, and select the “Join Team” link (at the top of the list of team members). Then, follow the instructions to register for the ALF Liver Life Walk as a part of Team Gratitude.

If you would like to support Team Gratitude in other towns, a few of the members will be participating in these ALF walks:

  • May 22, 2011: Eisenhower Park, NY.
  • June 12, 2011: Verona Park, NJ.

For information about Team Gratitude, contact Jessica Chipkin, at jessica.chipkin@gmail.com

For information about the American Liver Foundation and/or the Liver Life Walk, please contact ALF’s Event Manager, Dilber Koyuncu, at dkoyuncu@liverfoundation.org
or (212) 943-1059.

{ 0 comments }

Pamela Miles, Reiki Master

Pamela Miles

The Clinical Breast Cancer Program, a pioneer in testing the uses of complementary medicines in the treatment of cancer, will be hosting Pamela Miles, Reiki Master to speak at their Women’s Wellness Series on Thursday, February 24th. Drawing on her 25 years of reiki practice, Pamela will discuss the uses of reiki for health and well-being with a focus on how it benefits the breast cancer patient.

Pamela is an innovator in the reiki field, developing programs for prominent New York City hospitals, as well as speaking on the collaboration of reiki and traditional medicine at National Institute of Health events and at Harvard’s and Yale’s medical schools.

The Women’s Wellness Series is held every Thursday beginning at 4:00 PM in The Irving Cancer Research Center located at 1130 St. Nicholas Avenue in Washington Heights. If you are interested in attending this free event, please contact Kris Smith at 212-342-3911 or ks2666@columbia.edu.

If you cannot make this event, and would like more information about reiki, Pamela’s book, Reiki: A Comprehensive Guide, can be purchased at Amazon.com.

Related Link:
Wellness Series for Women Living with Breast Cancer Hosts Susan of Purple Shawl

{ 0 comments }

To achieve its mission of improving detection and treatment of pancreatic cancer, the Pancreas Center maintains a rigorous research program. Patients seeking treatment at the center may be eligible to participate in one or more trials, including the first trial of a non-invasive method of screening for pancreatic cancer. By participating in trials, patients can gain access to screening and therapeutic modalities before they are available elsewhere, and their participation helps to advance research efforts in pancreatic cancer.

New trials in 2011 include:

Participation in all studies is voluntary. Read more about all trials at the Center, and how you may participate, by clicking here.

{ 2 comments }